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Background: Pulmonary rehabilitation (PR) is recommended after a severe COPD exacerbation, 
but its short- and long-term effects on health care utilization have not been fully established.
Aims: The aims of this study were to evaluate patient compliance with a chronic disease 
management (CDM) program incorporating home-based exercise training as the main compo-
nent after a severe COPD exacerbation and to determine its effects on health care utilization 
in the following year.
Materials and methods: COPD patients with a severe exacerbation were included in a case-cohort 
study at admission. An intervention group participated in a nurse-supervised CDM program 
during the 2 months after discharge, comprising of home-based PR with exercise components 
directly supervised by a physiotherapist, while the remaining patients followed usual care.
Results: Nineteen of the twenty-one participants (90.5%) were compliant with the CDM program 
and were compared with 29 usual-care patients. Compliance with the program was associated 
with statistically significant reductions in admissions due to respiratory disease in the following 
year (median [interquartile range]: 0 [0–1] vs 1 [0–2.5]; P=0.022) and in days of admission 
(0 [0–7] vs 7 [0–12]; P=0.034), and multiple linear regression analysis confirmed the protective 
effect of the CDM program (β coefficient -0.785, P=0.014, and R2=0.219).
Conclusion: A CDM program incorporating exercise training for COPD patients without 
limiting comorbidities after a severe exacerbation achieves high compliance and reduces admis-
sions in the year following after the intervention.
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Introduction
COPD has a high prevalence worldwide1 and is forecast to be the world’s fourth largest 
cause of mortality by 2030.2 COPD exacerbations are characterized by increases in 
the patient’s baseline dyspnea and sputum production and/or the appearance of puru-
lence, which may warrant a change in regular medication, and are associated with a 
greater probability of recurrence and death.3,4 Admissions due to a severe exacerbation 
are associated with a significant reduction in physical activity5,6 and with impaired 
exercise capacity after discharge,7 which may be improved through exercise training.8 
Pulmonary rehabilitation (PR) increases exercise tolerance in COPD.9,10 It has been 
shown to reduce the use of health care resources11,12 and shorten subsequent admis-
sions and hospital stays due to respiratory disease in stable COPD; however, its role in 
COPD exacerbations is controversial. The current evidence suggests that PR is feasible 
when introduced immediately after an exacerbation,13 and a recent review14 concluded 
that PR following these acute episodes is associated with statistically significant and 
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clinically relevant improvements in 6-minute walking test 
(6MWT) and shuttle test.
The current guidelines consider PR as a safe procedure 
within 1 month of hospital discharge9 and recommend its 
use in COPD patients,15 suggesting that its implementation 
in this clinical setting requires an interdisciplinary approach 
combining respiratory medicine, rehabilitation, and social 
and behavioral sciences and focusing on effective and 
individualized strategies to improve physical activity.16,17 
However, the contents of successful PR programs carried 
out to date have varied widely,18–20 and previous reports 
have identified comorbidities, transport to the rehabilita-
tion center, and schedules as the main obstacles to their 
implementation.21
The aims of this study were to evaluate the compli-
ance with a chronic disease management (CDM) program 
incorporating home-based PR with exercise training as its 
main component after a severe exacerbation in a selected 
population of COPD patients and to determine the effects of 
this program on health care use the following year, focusing 
on admissions due to respiratory disease after discharge as 
primary outcome.
Materials and methods
study design and population
Determinants of recurrent admission after a severe COPD 
exacerbation were assessed through a case-cohort study,22 
nested in an open cohort consisting of all patients admitted 
to a university hospital from January 2011 to June 2012 for 
an exacerbation of COPD who reported previous admis-
sions due to the same cause. Patients admitted with this 
primary diagnosis (ICD9 491.21, 491.22, 492.8, 493.2, 
and 494.1; or 518.81 and 518.84, with any of the previous 
ICD9 categories as a second diagnosis) were identified and 
included in the cohort, when a diagnosis of COPD had been 
established according to the American Thoracic Society/
European Respiratory Society guidelines23 and based on a 
spirometry performed the previous year during stability. The 
inclusion criterion for the case-cohort study was a record 
of a previous admission for a severe COPD exacerbation 
during the previous 3 years, registered in any of the hospitals 
of the region and/or primary card records. Patient frailty, 
defined as one or more comorbidities limiting cognitive 
or exercise capabilities, a cluster of $3 admissions in the 
previous year, or an admission lasting over 30 days during 
the same period were exclusion criteria. Patients under the 
age of 40, with a lifetime diagnosis of asthma, cystic fibrosis, 
neoplasia, or bronchiectasis as a primary diagnosis, or those 
receiving long-term treatment with oral corticosteroids 
or immunosuppressors were also excluded. Participating 
patients were enrolled over an 18-month period and were 
followed for 1 year after enrollment. 
Patients included in the case-cohort study were ascribed 
every day to the intervention or the control groups in accor-
dance with their hour of admission during the 18 months of 
enrollment. The first admitted patient of the day fulfilling 
the inclusion criteria for the case-cohort study was invited to 
participate in the CDM program, while subsequent patients 
who met the inclusion criteria conformed to the control 
group and followed usual care. The study was designed to 
include a minimum of 50 patients, with a minimal recruitment 
period of 1 year, estimated from the ten percent prevalence 
of enrollment criteria in COPD exacerbations admitted to the 
hospital the previous years. The study protocol was approved 
by the ethics committee of the Hospital Universitari Parc 
Taulí and an informed consent was given by all participants 
in the CDM program.
Variables and measurements
Sociodemographic data were recorded at enrollment by 
means of a questionnaire that investigated smoking habit, 
current respiratory symptoms, comorbidities, and previous 
exacerbations. Lung function values during stability were 
obtained from the most recent available forced spirometry 
with reversibility testing performed during the previous year 
according to standard techniques24 with the same dry rolling 
seal spirometer (Spirometrics, Gray, ME, USA). Forced vital 
capacity (FVC) and expiratory volume in the first second 
(FEV
1
) were recorded for the study, and were expressed as 
postbronchodilator absolute values (mL) and percentages 
of the reference values, using age- and height-adjusted ref-
erence values obtained from selected volunteers from the 
Barcelona province.25
Acute episodes of increased dyspnea and sputum produc-
tion and/or purulence during the year after discharge were 
identified as exacerbations26,27 and were considered in the pres-
ent study when treated with antibiotics and/or oral corticoster-
oids by the attending physician in the primary care setting or 
at hospital in accordance with the guidelines.28 Exacerbations 
and mortality during the year after enrollment were recorded 
from hospital and primary care records, and acute episodes 
were considered as severe when requiring an admission over 
24 hours. The number of admissions due to respiratory causes 
in the year after enrollment was the primary outcome of the 
study, while days of hospitalization of these admissions and 
mortality due to any cause were the secondary outcomes.
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Intervention
As part of usual care, all participants received education on 
prescribed oral and inhaled treatment and recommendations 
for physical activity during their admission. Current smokers 
were referred to a smoking cessation program in accordance 
with the guidelines.29 The CDM program was implemented 
immediately after discharge by physicians, nurses, and phys-
iotherapists from the hospital and primary care setting. The 
intervention group followed PR for 2 months immediately 
after discharge which included exercise training as a main 
component. The CDM program included nurse supervision 
of treatment adherence with scheduled monthly calls to check 
health status and compliance and by unscheduled phone con-
sultations with the nurse when required. The home-based PR 
followed by the intervention group consisted of an 8-week 
program directly supervised by a physiotherapist team, which 
included exercise components previously validated in clinical 
trials.20,30–32 PR started within 72 hours of hospital discharge 
and consisted of 1 hour of exercise training at home twice 
per week for 8 weeks. After the first week of home-based 
PR, an individualized daily training plan was proposed to 
the patient, and compliance with this plan was checked 
in the following sessions by the physiotherapist through a 
checklist-based interview. Exercise training included respira-
tory physiotherapy, practice in energy-saving techniques, and 
endurance and strength exercises for the peripheral muscles. 
Exercise intensity and duration were gradually increased 
over time by the physiotherapist on an individualized basis 
in the presential sessions. After the 2-month scheduled PR 
at patient’s home, compliance with the individualized exer-
cises was supervised every month at follow-up nurse calls 
during 1 year. Functional capacity was measured in patients 
in the intervention group through forced spirometry, oxygen 
saturation, and 6MWT in accordance with the American 
Thoracic Society guidelines and using standardized instruc-
tions and encouragement.33 Measurements were performed 
48–72 hours after discharge, at the end of PR, and 6 months 
after enrollment. 
statistical analysis
Data were analyzed using the SPSS statistical software 
package version 18 (SPSS Inc., Chicago, IL, USA). Results 
for categorical variables are expressed as absolute and 
relative frequencies, and results for continuous variables as 
means (standard deviation [SD]) or as medians (percentile 
25–75 [P25–P75]) when the distribution was not normal. 
Exacerbations requiring treatment during the year after dis-
charge (both moderate and severe) and mortality in the same 
period were calculated. Admissions due to a severe COPD 
exacerbation were considered as the primary outcome and 
inpatient days due to respiratory disease and mortality due to 
any cause as the secondary outcomes, so as to determine the 
protective effect of the program on severe exacerbations.
First, compliance with the CDM program (ie, participa-
tion in .80% of PR sessions) was determined in participants; 
second, admission frequencies, inpatient days, and mortality 
were compared in patients on the program and usual-care 
patients (chi-square test, Student’s t-test, and non-parametric 
test, as required). Finally, univariate and multivariate linear 
regression analyses were used to analyze the association 
between independent variables and the main outcome, 
including all variables showing a significance up to 0.10% in 
the models. All analyses were performed including only par-
ticipants compliant with the CDM program (“pre-protocol”), 
while a secondary multivariate linear regression analysis was 
performed in accordance with “intention-to-treat” criteria, 
including both compliant and non-compliant patients in the 
intervention group.
Results
A total of 67 out of 837 severe exacerbations examined 
during the recruitment period appeared in patients with a 
previous admission due to acute respiratory disease in the 
previous 3 years. Fifty of them appeared in COPD patients 
with clinically significant comorbidities who accomplished 
the criteria for the present case-cohort study. Twenty-one of 
these were selected for participation in the CDM program that 
was accepted by 19 of them (90.5%), who participated in over 
80% of the scheduled PR sessions. Two patients declined to 
participate within 2 weeks of enrollment (9.5%), and hence 
they were excluded from subsequent “per-protocol” analyses. 
Participants were compared with the remaining 29 usual-care 
patients who made up the control group (Figure 1). Patients 
in intervention and control groups were homogeneous in 
terms of age, gender, smoking status, comorbidities, lung 
function, and number of exacerbations in the previous year 
(Table 1).
Statistically significant improvements in lung volume, 
oxygen saturation, and exercise capacity were observed 
2 months after discharge in participants compliant with the 
CDM program compared with their values at admission. 
FVC (%) increased from 63.1 (SD 15.8) to 71.6 (15.3) 
(P=0.018, Student’s t-test) and oxygen saturation (%) from 
92 (SD 2) to 95 (SD 1) (P,0.001, Student’s t-test). Similarly, 
6MWT improved from 278.9 (SD 89.7) to 344.2 m (SD 59.8) 
(P=0.003, Student’s t-test). These improvements were 
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maintained half a year after the admission. Changes in the 
other lung function parameters measured did not reach sta-
tistical significance.
During the 2 months of follow-up after enrollment, the 
19 COPD patients compliant with the CDM program expe-
rienced a similar number of exacerbations than the 29 usual-
care patients (P=0.159, Mann–Whitney U-test) and also an 
equivalent number of admissions (P=0.741, Mann–Whitney 
U-test) (Table 2). Patients following the program and those 
with usual care also experienced a similar number of exac-
erbations when considering the whole year after enrollment 
(median 2 [interquartile range 1–5] vs 3 [1–5], respectively, 
P=0.166, Mann–Whitney U-test), but participants compliant 
with the CDM program had fewer admissions due to severe 
exacerbation (0 [0–1] vs 1 [0–2.5], P=0.022, Mann–Whitney 
U-test) and spent fewer days in hospital (0 [0–7] vs 7 [0–12], 
P=0.034, Mann–Whitney U-test). Mortality in the year after 
enrollment was below 10% in both groups and there were no 
statistically significant differences between them (Table 2).
In the regression analyses, compliance with the CDM 
program was inversely associated with the number of 
admissions due to respiratory disease in the year after enroll-
ment (P=0.014), together with postbronchodilator FEV
1
% 
(P=0.025). Multiple linear regression analysis confirmed 
both predictors as determinants and the program’s protec-
tive role against the appearance of severe exacerbations 
during follow-up, since the greater part of the variance 
in this outcome in the multivariate model was explained 
by the participation in the program (R²=0.219) (Table 3). 
Figure 1 Enrollment flow diagram.
Assessed for eligibility (n=837)
Excluded (n=770)
Not meeting inclusion criteria
♦ Fragility
♦ >1 previous exacerbation
Intervention (n=19)
Lost to follow-up (n=0)
Allocated to intervention (n=21)
Received allocated intervention (n=21)
Lost to follow-up (n=0)
Allocated to usual care (n=29)
Allocation
Analysis
Follow-up
Recruited (n=67)
Enrollment
Excluded due to severe
comorbidities (n=17)
Analyzed (n=19) Analyzed (n=29)
Table 1 Baseline characteristics: patients in chronic disease 
management (CDM) program and usual-care patients (n=48)
CDM 
programa
Usual- 
care
P-value
n 19 29 –
age (years; mean [sD]) 74.3 (7.6) 71.4 (6.8) 0.182
gender (women; n [%]) 1 (5.3) 2 (6.9) 1.000
Current smoking, n (%) 4 (21.1) 4 (13.8) 0.695
Charlson index, median (IQr) 2 (1–3) 2 (1–3) 0.816
Postbronchodilator FeV1%, mean (sD) 46.7 (10.6) 45.4 (14.7) 0.740
severe exacerbations previous year, 
median (IQr)
0 (0–1) 1 (0–1) 0.400
Note: aIncluding only patients compliant with the CDM.
Abbreviations: FeV1, expiratory volume in the first second; IQR, interquartile range.
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The CDM program attained similar results when considering 
the number of inpatient days due to respiratory disease 
2 months and 1 year after enrollment, after adjustment for 
covariates (P=0.595 and P=0.034, respectively). The sig-
nificance of the relationships between the program and the 
number of severe exacerbations and inpatient days was lost 
in the multiple regression analyses when both compliant 
and non-compliant patients in the intervention group were 
considered, in accordance with “intention-to-treat criteria” 
(P=0.262 and P=0.125, respectively).
Discussion
In the present study, compliance with a CDM program that 
included exercise training as a main component was above 
90% when targeting severe COPD exacerbation patients who 
had one previous admission for respiratory disease and had 
no limiting comorbidities. In this selected group of patients, 
the program was unable to reduce short-term readmissions 
after discharge, but it did achieve a statistically significant 
decrease in severe exacerbations the following year, paral-
leled by an equivalent decrease in the number of inpatient 
days due to respiratory disease.
The CDM program implemented after an admission due 
to COPD exacerbation and incorporating PR as its main 
component reduced severe exacerbations in the year after 
the intervention. In stable COPD patients, PR programs have 
shown their ability to minimize subsequent admissions and 
are recommended in the current guidelines,9 and they also 
improve exercise capacity in COPD patients after an admis-
sion for respiratory causes.8,9,31,34–36 PR during admission has 
not shown a significant effect on the frequency of readmission 
within a year,37 and when implemented after discharge, it does 
not consistently prevent short-term readmissions,18,20,32,38–40 
but exercise training has been reported to reduce readmis-
sions within a year of a severe exacerbation in some clinical 
trials30,41 and systematic reviews.40,42 In our study, PR with two 
weekly sessions of exercise training for 8 weeks scheduled 
after an admission did not prevent short-term readmissions, 
but it achieved a statistically significant reduction of severe 
exacerbations the year after discharge without affecting the 
frequency of exacerbations as a whole. This finding supports 
the hypothesis that exercise training reduces the severity 
of exacerbations and the need for hospital admissions, an 
effect that only becomes evident after the completion of the 
2-month rehabilitation program.
Integrated management programs including two or more 
interventions in COPD patients administered at two or more 
health care levels have been assessed in a variety of clinical 
Table 2 exacerbations and mortality 2 and 12 months after enrollment (n=48)
2 months 12 months
CDM 
programa
Usual- 
care
P-value CDM 
programa
Usual- 
care
P-value
n 19 29 – 19 29 –
exacerbationsb $1, n (%) 2 (10.5) 8 (27.6) – 8 (27.5) 25 (86.2) –
exacerbationsb median (IQr) 0 (0–0) 0 (0–0) 0.159 2 (1–5) 3 (1–5) 0.166
admissionsc $1, n (%) 2 (10.5) 4 (13.8) – 7 (36.8) 19 (65.5) –
admissionsc median (IQr) 0 (0–0) 0 (0–0) 0.741 0 (0–1) 1 (0–2.5) 0.022
Inpatient daysc median (IQr) 0 (0–0) 0 (0–0) 0.595 0 (0–7) 7 (0–12) 0.034
Mortalityd n (%) – – – 0 (0) 2 (6.9) 0.512
Notes: aIncluding patients compliant with the CDM program; btreated with antibiotics and/or corticosteroids; cdue to respiratory disease; dany cause.
Abbreviations: CDM, chronic disease management; IQR, interquartile range.
Table 3 Univariate and multivariate analyses of predictors of admissions 2 and 12 months after discharge (n=48)
Univariate linear regression 
(2 months)
Univariate linear regression 
(12 months)
Multivariate linear regression 
(12 months)
β 95% CI P-value β 95% CI P-value β 95% CI P-value
age -0.003 -0.017/0.011 0.665 -0.025 -0.072/0.021 0.109 – – –
gender -0.133 -0.537/0.270 0.509 0.444 -0.939/1.828 0.521 – – –
Current smoking 0.150 -0.110/0.410 0.251 0.250 -0.650/1.150 0.579 – – –
Charlson comorbidity index 0.073 -0.018/0.164 0.112 -0.036 -0.356/0.284 0.821 – – –
Postbronchodilator FeV1% -0.001 -0.008/0.007 0.835 -0.323 -0.053/-0.004 0.025 -0.027 -0.050/0.004 0.025
CDM program 0.033 -0.168/0.233 0.744 -0.354 -1.464/-0.177 0.014 -0.785 0.170/1.401 0.014
Abbreviations: CDM, chronic disease management; FeV1, expiratory volume in the first second.
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settings.43–46 These programs have been shown to be safe47 
and to exert a protective effect against severe exacerbations 
when they incorporate exercise training.44–46,48 Interventions 
based on self-management alone have not attained equivalent 
results, with improvements restricted to disease coping and 
treatment adherence,49–51 that are not paralleled by an impact 
on admissions in the following year,48,51–53 with one study even 
reporting a potential negative effect on survival.50 A similar 
lack of effect on subsequent admissions has been reported 
for telemonitoring interventions54,55 and for other outpatient 
interventions restricted to a single component.56 In keeping 
with previous CDM programs that have demonstrated well-
defined effects on subsequent admissions, the intervention 
carried out in our study was designed to be both multilevel and 
multicomponent, and included education and nurse-assisted 
management at hospital and primary care levels, combined 
with PR at home directly supervised by physiotherapists.
The CDM intervention implemented in the present 
study attained statistically significant improvements in lung 
volume, oxygen saturation, and exercise capacity in the 
patients compared with their discharge values. 6MWT had an 
average improvement of over 60 m, as has been previously 
reported with exercise training,8,31 surpassing the distance 
considered as clinically significant.34,57,58 This improvement, 
accordingly, may be ascribed to the rehabilitation component 
of the CDM program.
The CDM program had a compliance rate of above 90% 
for all its components, higher than the previously reported 
rates.59–61 Lack of compliance in exercise training programs 
has been attributed to transport and scheduling difficulties, 
comorbidities, and/or a rejection of the hospital setting.60 The 
high compliance rate attained in the present study must be 
partly related to patient selection, considering that patients 
with advanced disease, multiple admissions, or clinically 
significant comorbidities were not considered, and to the 
inclusion of the PR in an integrated CDM program carried out 
for the most part in the patient’s home. Higher success rates 
of PR have been previously reported when exercise training 
has been implemented as part of multicomponent programs 
involving physicians, nurses, and physiotherapists.43
Limitations of the study were, first, the number of 
patients participating in the case-cohort study, and, second, 
the design restriction to patients reporting a single previous 
exacerbation. Accordingly, the positive results of the present 
study cannot be extrapolated to COPD patients with frequent 
severe exacerbations who are commonly found as inpatients 
in most hospitals. Recurrent admissions are often related to 
comorbidities that limit participation in exercise training and 
render patients ineligible for PR programs.59 Focusing on 
COPD patients who reported two single severe exacerbations 
restricts the target to only one tenth of admissions in a general 
hospital, also, it gives relevance to the study considering that 
this patient population is easily identifiable, where positive 
results with CDM programs may be expected.
Conclusion
In conclusion, a 2-month integrated CDM program including 
exercise training for COPD patients with a severe exacerba-
tion attained a compliance rate of 90% and reduced subse-
quent admissions due to respiratory disease after the end 
of the intervention. PR as part of a multicomponent CDM 
program exerts a protective effect on recurrent admissions in 
COPD patients who do not have either limiting comorbidities 
or multiple admissions.
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